OTC · CIK 0001831283
LIANY LianBio
Insider trading from SEC Form 4. Last filing Apr 11, 2024. Close $0.05 on Oct 13, 2026, +59% from the 52-week low and -71% from the high.
In brief
LianBio (LIANY) has 18 SEC Form 4 filings on file from 11 insiders, the latest filed on Apr 11, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at LIANY. The newest: Ehong Gu (Interim CFO) sold $7,513 of stock on Jan 2, 2024, filed Apr 11, 2024, scored 22 (weak).
2 Form 144 notices of planned sales are on file, the latest filed Jan 8, 2024.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at LianBio, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Ehong Gu Interim CFO sell | $7,513 1,731 shares | -2% | -5% from low+229% from high | |
| 15Weak | Jiang Qian SVP, China General Manager sell | $3,702 2,239 shares | -3% | -75% from low+38% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 8, 2024 | Wang Yizhe Officer, OFFICER FORMER CEO | 820,000 0.77% of outstanding | $3.4M | Jan 8, 2024 | $939k |
| Dec 29, 2023 | Wang Yizhe Officer, FORMER CEO | 250,000 0.23% of outstanding | $1.1M | Dec 29, 2023 | none |
Transactions
Every row filed, 33 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Ehong Gu Interim CFO | SOpen-market sale Ordinary Shares | -1,731 | $4.34 | $7,513 | 76,762 | Apr 11, 2024 |
| Apr 9, 2024 | Ehong Gu Interim CFO | DDisposition to issuer Ordinary Shares | -17,889 | $0.32 | $5,724 | 0 | Apr 11, 2024 |
| Feb 15, 2024 | Perceptive Advisors LLC director, owner | MOption exercise Ordinary Sharesindirect: See footnote | +36,300 | $2.52 | $91k | 36,300 | Feb 20, 2024 |
| Feb 15, 2024 | Susan Michele Silbermann director | MOption exercise Ordinary Shares | +36,300 | $2.52 | $91k | 36,300 | Feb 20, 2024 |
| Feb 15, 2024 | Konstantin Poukalov director | MOption exercise Ordinary Shares | +36,300 | $2.52 | $91k | 36,300 | Feb 20, 2024 |
| Feb 15, 2024 | Adam Leo Stone Interim CEO | MOption exercise Ordinary Shares | +36,300 | $2.52 | $91k | 36,300 | Feb 20, 2024 |
| Feb 15, 2024 | Anastasios Gianakakos director | MOption exercise Ordinary Shares | +36,300 | $2.52 | $91k | 72,848 | Feb 20, 2024 |
| Feb 15, 2024 | Anastasios Gianakakos director | FTax withholding Ordinary Shares | -19,218 | $4.76 | $91k | 53,630 | Feb 20, 2024 |
| Feb 15, 2024 | Adam Leo Stone Interim CEO | FTax withholding Ordinary Shares | -19,218 | $4.76 | $91k | 17,082 | Feb 20, 2024 |
| Feb 15, 2024 | Konstantin Poukalov director | FTax withholding Ordinary Shares | -19,218 | $4.76 | $91k | 17,082 | Feb 20, 2024 |
| Feb 15, 2024 | Susan Michele Silbermann director | FTax withholding Ordinary Shares | -19,218 | $4.76 | $91k | 17,082 | Feb 20, 2024 |
| Feb 15, 2024 | Perceptive Advisors LLC director, owner | FTax withholding Ordinary Sharesindirect: See footnote | -19,218 | $4.76 | $91k | 17,082 | Feb 20, 2024 |
| Feb 15, 2024 | Adam Leo Stone Interim CEO | MOption exercise Stock Option (Right to Buy)derivative | -36,300 | $0.00 | $0 | 0 | Feb 20, 2024 |
| Feb 15, 2024 | Konstantin Poukalov director | MOption exercise Stock Option (Right to Buy)derivative | -36,300 | $0.00 | $0 | 0 | Feb 20, 2024 |
| Feb 15, 2024 | Perceptive Advisors LLC director, owner | MOption exercise Ordinary Sharesindirect: See footnote | +36,300 | $2.52 | $91k | 36,300 | Feb 20, 2024 |
| Feb 15, 2024 | Susan Michele Silbermann director | MOption exercise Stock Option (Right to Buy)derivative | -36,300 | $0.00 | $0 | 0 | Feb 20, 2024 |
| Feb 15, 2024 | Anastasios Gianakakos director | MOption exercise Stock Option (Right to Buy)derivative | -36,300 | $0.00 | $0 | 0 | Feb 20, 2024 |
| Feb 15, 2024 | Perceptive Advisors LLC director, owner | FTax withholding Ordinary Sharesindirect: See footnote | -19,218 | $4.76 | $91k | 17,082 | Feb 20, 2024 |
| Feb 15, 2024 | Perceptive Advisors LLC director, owner | MOption exercise Stock Option (Right to Buy)derivativeindirect: See Footnote | -36,300 | $0.00 | $0 | 0 | Feb 20, 2024 |
| Feb 15, 2024 | Perceptive Advisors LLC director, owner | MOption exercise Stock Option (Right to Buy)derivativeindirect: See Footnotes | -36,300 | $0.00 | $0 | 0 | Feb 20, 2024 |
| Jun 21, 2023 | Wei Wei Chen director | AGrant or award Stock Option (Right to Buy)derivative | +36,300 | $0.00 | $0 | 36,300 | Jun 23, 2023 |
| Jun 21, 2023 | Anastasios Gianakakos director | AGrant or award Stock Option (Right to Buy)derivative | +36,300 | $0.00 | $0 | 36,300 | Jun 23, 2023 |
| Jun 21, 2023 | Perceptive Advisors LLC director, owner | AGrant or award Stock Option (Right to Buy)derivativeindirect: See Footnotes | +36,300 | $0.00 | $0 | 36,300 | Jun 23, 2023 |
| Jun 21, 2023 | Perceptive Advisors LLC director, owner | AGrant or award Stock Option (Right to Buy)derivativeindirect: See Footnotes | +36,300 | $0.00 | $0 | 36,300 | Jun 23, 2023 |
| Mar 29, 2023 | Brianne Jahn Chief Business Officer | AGrant or award Ordinary Shares | +224,005 | $0.00 | $0 | 224,005 | Mar 31, 2023 |
| Mar 29, 2023 | Yi Larson Chief Financial Officer | AGrant or award Ordinary Shares | +325,901 | $0.00 | $0 | 325,901 | Mar 31, 2023 |
| Mar 29, 2023 | Yizhe Wang Chief Executive Officer | AGrant or award Ordinary Shares | +907,498 | $0.00 | $0 | 907,498 | Mar 31, 2023 |
| Mar 29, 2023 | Jiang Qian SVP, China General Manager | AGrant or award Ordinary Shares | +224,005 | $0.00 | $0 | 291,354 | Mar 31, 2023 |
| Jan 20, 2023 | Brianne Jahn Chief Business Officer | AGrant or award Stock Option (Right to Buy)derivative | +318,995 | $0.00 | $0 | 318,995 | Jan 24, 2023 |
| Jan 20, 2023 | Yi Larson Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +464,099 | $0.00 | $0 | 464,099 | Jan 24, 2023 |
| Jan 20, 2023 | Yizhe Wang Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +1,292,324 | $0.00 | $0 | 1,292,324 | Jan 24, 2023 |
| Jan 20, 2023 | Jiang Qian SVP, China General Manager | AGrant or award Stock Option (Right to Buy)derivative | +318,995 | $0.00 | $0 | 318,995 | Jan 24, 2023 |
| Jan 3, 2023 | Jiang Qian SVP, China General Manager | SOpen-market sale Ordinary Shares | -2,239 | $1.65 | $3,702 | 67,349 | Jan 5, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Wei Wei Chendirector
- Anastasios Gianakakosceo, president, officer, director
- Ehong GuInterim CFO
- Brianne JahnChief Business Officer
- Yi LarsonChief Financial Officer
- Perceptive Advisors LLCdirector, owner, other
- Konstantin Poukalovdirector, officer
- Jiang QianSVP, China General Manager
- Susan Michele Silbermanndirector
- Adam Leo StoneInterim CEO
- Yizhe WangChief Executive Officer
Questions about LIANY
Answered from the filings on this page, as of the latest one.
Are insiders buying LIANY?
No. In the last 90 days no insider at LianBio bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade LIANY on the open market?
Ehong Gu (Interim CFO) sold $7,513 of LIANY on Jan 2, 2024 and filed the Form 4 on Apr 11, 2024. InsiderTell scored 22 (weak).
How many insiders file Form 4 at LianBio?
11 people have filed a Form 4 at LianBio, among them Wei Wei Chen (director), Anastasios Gianakakos (CEO, president and director), Ehong Gu (Interim CFO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.